Literature DB >> 19597823

[Volume overload from hydrogel expander after treatment for enophthalmos].

M Küstner1, P Riebeling, F Podmelle, W Kaduk, F Tost.   

Abstract

In the subject of this case report, a self-inflating hydrogel expander was implanted as a treatment for posttraumatic enophthalmos in a fully sighted eye. The intervention caused hypertropia with diplopia, restriction of eye movements, visual field defects, and colour desaturation as a result of excessive swelling of the expander. Once the expander volume was adjusted, clinical signs regressed, and the aesthetic results were excellent. Following the implantation of self-inflating orbit expanders, it is advisable to carry out immediate follow-up during the expander's swelling period, and long-term follow-up is also advised to rule out late sequelae, as a position-dependent secondary glaucoma could occur.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19597823     DOI: 10.1007/s00347-009-1995-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  4 in total

1.  Osmotically induced tissue expansion with hydrogels: a new dimension in tissue expansion? A preliminary report.

Authors:  K G Wiese
Journal:  J Craniomaxillofac Surg       Date:  1993-10       Impact factor: 2.078

2.  Injectable self inflating hydrogel pellet expanders for the treatment of orbital volume deficiency in congenital microphthalmos: preliminary results with a new therapeutic approach.

Authors:  M P Schittkowski; R F Guthoff
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

Review 3.  Use of self-expanding, hydrophilic osmotic expanders (hydrogel) in the reconstruction of congenital clinical anophthalmos.

Authors:  Robert A Mazzoli; William R Raymond; Darryl J Ainbinder; Elizabeth A Hansen
Journal:  Curr Opin Ophthalmol       Date:  2004-10       Impact factor: 3.761

4.  [Treatment of congenital clinical anophthalmos with high hydrophilic hydrogel expanders].

Authors:  M P Schittkowski; K K H Gundlach; R F Guthoff
Journal:  Ophthalmologe       Date:  2003-06-25       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.